Acorda

Acorda is a biopharmaceutical firm that develops and commercializes novel therapeutics for the treatment of neurological disorders.

Business Model:

Revenue: $122.7M

Employees: 51-200

Detailed Acorda Information

Geographic Data

Acorda headquarters map

Address: 420 Saw Mill River Rd.

City: Ardsley

State: NY

Zip: 10502

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$10M

Raised Total:

$152M

Metrics

4,719,878Website Global Rank

2,007Website Monthly Traffic

Twitter Followers

Description

Acorda is a biopharmaceutical firm that develops and commercializes novel therapeutics for the treatment of neurological disorders.

Contact Phone:
+19143474300

Contact Email:

Acorda went public on 2/10/2006 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/10/2006

Ticker Symbol:
ACOR

IPO Price:
$6/share

Amount Raised:
$33M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2006 IPO $33M
3/2004 Venture Round $11.5M
10/2003 Grant 2 $380k National Institute of Neurological Disorders and Stroke
New York State Department of Health
National Institute of Neurological Disorders and Stroke
New York State Department of Health
12/2002 Grant 1 $980k NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
11/2006 Post-IPO Equity 1 $10M Paul Capital
Paul Capital
Paul Capital
Paul Capital
10/2006 Post-IPO Equity $31.5M
5/2003 Series B 7 $55.3M Cross Atlantic Partners
J.P. Morgan Securities Inc.
Forbion Capital Partners
MPM Capital
Forward Ventures
ABN AMRO Fund
Easton Capital
Easton Capital
Cross Atlantic Partners
J.P. Morgan Securities Inc.
Forbion Capital Partners
MPM Capital
Forward Ventures
ABN AMRO Fund
Easton Capital
Easton Capital
8/2001 Grant 1 $100k NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
3/2001 Series A 1 $6M Merrill Lynch Ventures
Merrill Lynch Ventures
1/2001 Series A $0 Forward Ventures
BayStar Capital
China Development Industrial Bank (CDIB)
Novartis Venture Fund
RBC Venture Partners
Swiss Life Private Equity Partners
Forward Ventures
BayStar Capital
China Development Industrial Bank (CDIB)
Novartis Venture Fund
RBC Venture Partners
Swiss Life Private Equity Partners
10/1997 Grant $2M
8/2002 Grant 1 $139k NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
1/2001 Series A 6 $33.7M Forward Ventures
Forward Ventures
Announced Date Name Price
1/2016 Biotie Therapies
9/2014 Civitas Therapeutics
2/2012 Neuronex

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research